Skip to main content
OUTCOME
3.2
Communicable diseases, antimicrobial resistance, and immunization
Disease prevention, control, and elimination
PB
2026-2027
Communicable diseases, antimicrobial resistance, and immunization
3.2. Prevention, control, and elimination of communicable diseases and related conditions accelerated and sustained
Budget
Approved Budget PB (Previous)
127.3
US$ MILLION
Priority

High

Proposed Budget PB (Current)
122.4
US$ MILLION
Related Outputs and Indicators
  • 3.2.1.a Number of countries and territories provided with technical cooperation to develop and implement national norms, standards, and tools aligned with specified internationally recognized guidelines on tuberculosis, HIV, viral hepatitis, and sexually transmitted infections
    Baseline
    10
    Target
    14
  • 3.2.1.b Number of countries and territories that have implemented a national envenoming program (venomous animals)
    Baseline
    2
    Target
    15
  • 3.2.1.c Number of countries and territories that have implemented integrated actions to prioritize zoonotic diseases
    Baseline
    4
    Target
    13
  • 3.2.2.a Number of countries and territories provided with technical cooperation to develop implementation plans for multidisease elimination in line with PAHO Disease Elimination Initiative
    Baseline
    2
    Target
    33
  • 3.2.2.b(a) Number of previously endemic countries or territories that have initiated the process to validate or verify the elimination of one or more neglected tropical diseases, based on specified elimination protocols (Trachoma)
    Baseline
    0
    Target
    2
  • 3.2.2.b(b) Number of previously endemic countries or territories that have initiated the process to validate or verify the elimination of one or more neglected tropical diseases, based on specified elimination protocols (Yaws)
    Baseline
    0
    Target
    9
  • 3.2.2.b(c) Number of previously endemic countries or territories that have initiated the process to validate or verify the elimination of one or more neglected tropical diseases, based on specified elimination protocols (Leprosy)
    Baseline
    0
    Target
    4
  • 3.2.2.b(d) Number of previously endemic countries or territories that have initiated the process to validate or verify the elimination of one or more neglected tropical diseases, based on specified elimination protocols (Lymphatic filariasis)
    Baseline
    2
    Target
    2
  • 3.2.2.b(e) Number of previously endemic countries or territories that have initiated the process to validate or verify the elimination of one or more neglected tropical diseases, based on specified elimination protocols (Onchocerciasis)
    Baseline
    3
    Target
    3
  • 3.2.2.b(f) Number of previously endemic countries or territories that have initiated the process to validate or verify the elimination of one or more neglected tropical diseases, based on specified elimination protocols (Human Rabies transmitted by dogs)
    Baseline
    1
    Target
    14
  • 3.2.2.c Number of countries and territories expanding access to malaria diagnosis and treatment with participation of the affected communities or general health services
    Baseline
    4
    Target
    18
  • 3.2.3.a Number of countries and territories provided with technical cooperation for the preparation of elimination of mother-to-child transmission roadmaps
    Baseline
    7
    Target
    25
  • 3.2.3.b Number of countries implementing the clinical bundle for the care of patients with suspected arboviral diseases
    Baseline
    8
    Target
    10
  • 3.2.3.c Number of countries and territories that implement person centered strategies for the elimination of HIV and tuberculosis
    Baseline
    1
    Target
    9
  • 3.2.4.a Number of countries and territories provided with technical cooperation to report on specified internationally recommended indicators for HIV, tuberculosis, viral hepatitis and selected sexually transmitted infections
    Baseline
    3
    Target
    13
  • 3.2.4.b Number of countries and territories that have implemented foodborne disease surveillance systems
    Baseline
    1
    Target
    5
  • 3.2.5.a Number of countries and territories implementing antimicrobial resistance awareness, education, and behavior change interventions, with a focus on key populations and community engagement
    Baseline
    5
    Target
    25
  • 3.2.5.b Number of countries and territories that have institutionalized national programs for infection prevention and control and/or antimicrobial stewardship as part of antimicrobial resistance containment efforts
    Baseline
    4
    Target
    15
  • 3.2.5.c. Number of countries and territories provided with technical cooperation to report quality data through PAHO's enhanced antimicrobial resistance surveillance platform
    Baseline
    4
    Target
    21
  • 3.2.6.a Number of countries and territories that PASB directly supported to develop a prioritized immunization plan, including PAHO-provided tools for immunization program strengthening
    Baseline
    4
    Target
    23
  • 3.2.6.b Number of countries and territories implementing digital interoperable vaccine preventable disease surveillance systems
    Baseline
    3
    Target
    19
  • 3.2.6.c Number of countries and territories that are implementing microplanning following the PAHO guidelines and tools to reach under vaccinated population
    Baseline
    3
    Target
    25
Key Interventions

    • Provide guidance and technical cooperation to improve access to people-centered health services for all through the development of policies, governance mechanisms, and financing strategies for the prevention, control, and elimination of communicable diseases, and to sustain elimination gains. 

    • Increase access to essential health technologies by strengthening national regulatory systems and supply chains and building national capacities for diagnostics, vaccines, vector control, and treatment. 

    • Enhance country capacity to improve surveillance systems, laboratory services, and information systems by developing and disseminating tools for risk assessment, integrated surveillance, and antimicrobial resistance monitoring to strengthen early warning and response. 

    • Provide leadership for multisectoral coordination and network synergies to support the development of guidance, strategies, and interventions based on an approach that recognizes the interconnectedness of human, animal, and environmental health, working among ministries, civil society, the private sector, and other stakeholders to integrate antimicrobial resistance mitigation and food safety into disease prevention, control, and elimination strategies. 

    • Facilitate participatory processes that empower civil society and communities in the planning, implementation, and monitoring of service delivery, decision-making, and local monitoring to sustain progress in disease prevention, control, and elimination.